Company overview

The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer. Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Netiquette & Privacy Notice: https://bit.ly/48X6JSN
Founded in 2003
New York, New York, USA
735 employees (47 in marketing)
58% recommend to a friend
31% positive business outlook

Salaries

Typical salary range

$165,000 – $220,000

/ yr

Help build salary transparency at Menarini Stemline

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +18.5% year over year

Funding

Total funding

$195.1M

Last raise

$88M

Post IPO Equity, 7 years ago

Funding history

Aug 2019

Post IPO Equity Stemline Therapeutics · $88M

Jan 2019

Post IPO Equity Stemline Therapeutics · $92M

Jan 2012

Debt Financing Stemline Therapeutics · $740K

Apr 2010

Venture Round Stemline Therapeutics · $600K

Mar 2010

Venture Round Stemline Therapeutics · $1.3M

Apr 2008

Series A Stemline Therapeutics · $12.5M

Audience

Monthly website visitors
3.8K
Month over month+10.9%
Quarter over quarter-36.1%
Top sourceDirect (42.9%)
Ad budget per month$0.0
Average search rank56.1
Traffic source mix
Direct
42.9%
Search
35%
Social
12.3%
Referral
8.1%
Paid referral
1.3%

LinkedIn followers

Follower count and growth

Total followers

53.6K

12-mo growth

+48.3%

Monthly growth

+2.4%

News

Links